CORRECTION article
Front. Aging Neurosci.
Sec. Cellular and Molecular Mechanisms of Brain-aging
Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1670545
Correction: Optineurin overexpression ameliorates neurodegeneration through regulating neuroinflammation and mitochondrial quality in a murine model of amyotrophic lateral sclerosis
Provisionally accepted
Shumin Zhao1,2
Ranran Chen1,2
Yi An1Yali Zhang1,2
Cheng Ma1
Ying Gao1,2
Yanchao Lu1,2
Fei Yang1,2Xue Bai1,2*
Jingjing Zhang3*- 1Chifeng Municipal Hospital, Chifeng, China
- 2Inner Mongolia Medical University, Hohhot, China
- 3Dalian Medical University, Dalian, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Incorrect funding In the published article, there was an error in the Funding statement. The grant number for the Natural Science Foundation of Inner Mongolia Autonomous Region was incorrectly listed as the application code (2022SHZR1527). The correct Funding statement appears below. FUNDING Natural Science Foundation of Inner Mongolia Autonomous Region of China (2022MS08048). The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Amyotrophic Lateral Sclerosis, Apoptosis, Mitochondrial Quality, Neuroinflammation, Optineurin
Received: 21 Jul 2025; Accepted: 23 Jul 2025.
Copyright: © 2025 Zhao, Chen, An, Zhang, Ma, Gao, Lu, Yang, Bai and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xue Bai, Chifeng Municipal Hospital, Chifeng, China
Jingjing Zhang, Dalian Medical University, Dalian, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.